A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

Clinical trial NCT04660643 · COMPLETED

Trial details

NCT number: NCT04660643
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2021-03-29
Primary completion: 2023-04-25
Enrollment: 783

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.